Comment on “Hyperglycemia in pregnancy: sleep alterations, comorbidities, and pharmacotherapy”

Abstract

LETTER TO THE EDITORDear Editor, We were happy to read the article written by Facanha et al 1 .The study found that sleep problems in pregnant women with diabetes are very common, which might be type 1 diabetes (T1DM) and type 2 diabetes (T2DM) or gestational diabetes mellitus (GDM). Another finding of the study was metformin, a commonly used oral hypoglycemic drug, and higher parity were independently associated with poor sleep quality in GDM patients. Although their findings point to some problems and offer innovative ideas, we believe some issues should be further discussed.The purpose of this study has been detailed at the end of the introduction, that is, to examine the sleep quality and sleep duration of patients with hyperglycemia secondary to T1DM, T2DM, and GDM in the middle and late stages of pregnancy and to analyze the factors that may affect sleep status. However, in our opinion, the title of this article may have been enlarged. To make the title of this article more accurate and reasonable, we suggest changing the title of this article from "Hyperglycemia in pregnancy: sleep alterations, comorbidities, and pharmacotherapy" to "Mid-late pregnant women: The effect of blood glucose comorbidity on sleep and drug treatment."We found another article 2 pointing out that the Pittsburgh Sleep Quality Index (PSQI) cutoff score of 5 is more suitable